关于「明说是糖丸:开放标签安慰剂的三次检验」,《开放标签与价格标签》给出的定量结论是什么?

结论:第一章复算开放标签安慰剂的三次检验:2010 年试点第 21 天的效应量为 0.788,2021 年三臂试验中开放标签相对不服药为 0.434、与双盲安慰剂相差无几,2025 年元分析中自评效应为 0.39、客观效应只有 0.09。

数据口径:书中参数为示意;全部计算由书中程序生成;本书不是医疗建议,不宣称任何产品或做法对身体或健康有任何作用,书中流程与工具为非个人化经营建议。 书中以标注框区分已发表证据、可运行的 Python 计算(21 段程序)、原典与作者假说。

English version

对照数据表

下表数字由本章 Python 程序原样打印,可重新运行复现。 程序只用 Python 标准库与结论吻合的打印值: 0.09, 0.39, 2021, 2025

estimate SMD SE P(sup) NNT
2021, 11 trials0.72 0.168 0.695 2.6
2025 overall0.35 0.046 0.598 5.1
2025 clinical0.47 0.054 0.630 3.8
2025 non-clinical0.29 0.064 0.581 6.2
2025 self-report0.39 0.048 0.609 4.6
2025 objective0.09 0.105 0.525 19.7
2025 trim-and-fill0.28 0.048 0.578 6.4
self-report minus objective0.30, SE 0.115, z 2.60, p 0.0093
objective share of self-report effect0.231
2025 clinical over 2021 estimate0.653
implied spread of true effects (tau, approx)0.265
share of settings with true SMD below 00.094
查看完整验算程序
# Chapter 1. p13: Two meta-analyses, four years apart, and the gap
# between self-reported and objective outcomes.
# Published inputs: von Wernsdorff et al. (2021), Sci Rep: 11 trials,
# SMD 0.72 (95% CI 0.39 to 1.05). Fendel et al. (2025), Sci Rep: 63
# comparisons, n 4554, SMD 0.35 (0.26 to 0.44), prediction interval
# -0.17 to 0.87; clinical 0.47 (0.36 to 0.57); non-clinical 0.29 (0.17
# to 0.42); self-report 0.39 (0.30 to 0.49); objective 0.09 (-0.12 to
# 0.29); trim-and-fill 0.28 (0.18 to 0.37). SEs from the CIs, the
# z test of the self-report vs objective gap and the conversions are ours.
# 两次元分析:效应量的缩水与「自评 vs 客观」的落差。
import math
from statistics import NormalDist

Z = NormalDist()
Z975 = Z.inv_cdf(0.975)
ROWS = [("2021, 11 trials", 0.72, 0.39, 1.05),
        ("2025 overall", 0.35, 0.26, 0.44),
        ("2025 clinical", 0.47, 0.36, 0.57),
        ("2025 non-clinical", 0.29, 0.17, 0.42),
        ("2025 self-report", 0.39, 0.30, 0.49),
        ("2025 objective", 0.09, -0.12, 0.29),
        ("2025 trim-and-fill", 0.28, 0.18, 0.37)]


def nnt(d):
    # Kraemer and Kupfer: 1 / (2 * P(superiority) - 1)
    return 1 / (2 * Z.cdf(d / math.sqrt(2)) - 1)


print("estimate             SMD    SE     P(sup)  NNT")
se = {}
for name, d, lo, hi in ROWS:
    se[name] = (hi - lo) / (2 * Z975)
    print("{:<19} {:5.2f}  {:.3f}  {:.3f}  {:5.1f}".format(
        name, d, se[name], Z.cdf(d / math.sqrt(2)), nnt(d)))
gap = 0.39 - 0.09
s = math.hypot(se["2025 self-report"], se["2025 objective"])
z = gap / s
print("self-report minus objective: {:.2f}, SE {:.3f}, z {:.2f}, p {:.4f}"
      .format(gap, s, z, 2 * (1 - Z.cdf(z))))
print("objective share of self-report effect: {:.3f}".format(0.09 / 0.39))
print("2025 clinical over 2021 estimate: {:.3f}".format(0.47 / 0.72))
tau = (0.87 - 0.35) / Z975
print("implied spread of true effects (tau, approx): {:.3f}".format(tau))
print("share of settings with true SMD below 0: {:.3f}"
      .format(Z.cdf(-0.35 / tau)))

唯一数据源与引用

范雅福(Fan, Y.). (2026). 《开放标签安慰剂预测编码、价格标签期望增益与杯弓蛇影反安慰剂母典》第 1 章「明说是糖丸:开放标签安慰剂的三次检验」(版本 1.0.0). 5D Library. DOI 待发布

DOI 待发布 · 专著页正式发布后上线(本站暂无专著页) · 5DL-B-201 · v1.0.0 · CC-BY-NC-ND-4.0

BibTeX
@book{fan2026201,
  author    = {Fan, Yafu},
  title     = {Open-Label Placebos and Predictive Coding, Price-Tag Expectancy Gains and the Nocebo of the Bow in the Cup},
  year      = {2026},
  publisher = {5D Library},
  edition   = {1.0.0},
  note      = {DOI pending}
}

本书其他章节结论